Order Article Reprints

Wu C-P, Hung C-Y, Murakami M, Wu Y-S, Lin C-L, Huang Y-H, Hung T-H, Yu J-S, Ambudkar SV. P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhibitor Ensartinib in Cancer Cells. Cancers. 2022; 14(9):2341. https://doi.org/10.3390/cancers14092341

Wu, Chung-Pu, Cheng-Yu Hung, Megumi Murakami, Yu-Shan Wu, Chun-Ling Lin, Yang-Hui Huang, Tai-Ho Hung, Jau-Song Yu, and Suresh V. Ambudkar. 2022. "P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhibitor Ensartinib in Cancer Cells" Cancers 14, no. 9: 2341. https://doi.org/10.3390/cancers14092341

Wu, C.-P., Hung, C.-Y., Murakami, M., Wu, Y.-S., Lin, C.-L., Huang, Y.-H., Hung, T.-H., Yu, J.-S., & Ambudkar, S. V. (2022). P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhibitor Ensartinib in Cancer Cells. Cancers, 14(9), 2341. https://doi.org/10.3390/cancers14092341